Healthcare costs will be the deciding issue in the 2026 midterm elections

Voter concern about healthcare affordability outweighs all other economic issues heading into the midterms.

Overview Debates Related claims Topics Sources

Younger patients should receive priority when lifesaving treatment is scarce

Insurers should be barred from setting premiums using genetic tests

Publicly funded healthcare should cover infertility treatment

Medicare for All is a viable solution to the U.S. healthcare crisis

Medicare coverage of anti-obesity drugs would add about $35 billion to federal spending from 2026 to 2034

Semaglutide carries a regulator-confirmed risk of NAION, a very rare optic nerve condition

Semaglutide and tirzepatide are cost-effective for obesity at current net prices

Most adults with obesity but without diabetes stop GLP-1 drugs within a year

Medicare coverage of weight-loss drugs could save Medicare $175–245 billion over ten years

Governments should license publicly funded drug patents to competitors when prices are unaffordable

Healthcare should be free for everyone

Abdul El-Sayed's progressive platform is a political liability for Michigan Democrats

Senate Finance Committee Democrat Ron Wyden and other political critics characterized the Trump administration's October 2026 Medicare rebate as a desperate pre-election attempt to influence voters before the November 3, 2026 midterms

Pre-election cash payouts to Medicare enrollees unacceptably politicize federal assistance programs

Transgender women are women

Public funding should prioritize access to established fertility treatment over enhancement

The ACA enrollment removal process lacks adequate due process protections

Tying Medicare drug prices to international benchmarks will lower patient costs without reducing access to treatments

The finalized international pricing model covers too few drugs to meaningfully reduce Medicare spending

The federal government should impose work requirements on Medicaid beneficiaries